Back to Search

MARK FISCHL, M.D.

M.D.

Internal Medicine Physician

NPI: 1558302984IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

MD228902(OR)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE

Class of 1994

Research & Publications (20)

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
PMID 18373851·AIDS Res Ther·2008
8-other
Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.
PMID 14620390·Pharmacotherapy·2003
3-trial
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
PMID 12934177·J Infect Dis·2003
3-trial
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
PMID 19380868·Blood·2009
3-trial
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
PMID 18771406·J Infect Dis·2008
4-observational
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
PMID 18677028·JAMA·2008
6-review
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
PMID 17304157·Ther Drug Monit·2007
4-observational
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
PMID 17324111·Pharmacogenomics·2007
4-observational
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
PMID 17391891·J Pharm Biomed Anal·2007
8-other
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).
PMID 17527093·J Acquir Immune Defic Syndr·2007
2-rct

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
2020 CAPITOL ST NE
SALEM, OR 97303

Quick Facts

NPI
1558302984
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
32
Publications
20

Are you this provider?

Claim Your Profile